159 related articles for article (PubMed ID: 32383023)
1. Deferoxamine Ameliorates Compressed Spinal Cord Injury by Promoting Neovascularization in Rats.
Tang G; Chen Y; Chen J; Chen Z; Jiang W
J Mol Neurosci; 2020 Sep; 70(9):1437-1444. PubMed ID: 32383023
[TBL] [Abstract][Full Text] [Related]
2. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α.
Hou Z; Nie C; Si Z; Ma Y
Diabetes Res Clin Pract; 2013 Jul; 101(1):62-71. PubMed ID: 23726275
[TBL] [Abstract][Full Text] [Related]
3. Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis.
Jia P; Chen H; Kang H; Qi J; Zhao P; Jiang M; Guo L; Zhou Q; Qian ND; Zhou HB; Xu YJ; Fan Y; Deng LF
J Biomed Mater Res A; 2016 Oct; 104(10):2515-27. PubMed ID: 27227768
[TBL] [Abstract][Full Text] [Related]
4. The experimental study of hypoxia-inducible factor-1alpha and its target genes in spinal cord injury.
Xiaowei H; Ninghui Z; Wei X; Yiping T; Linfeng X
Spinal Cord; 2006 Jan; 44(1):35-43. PubMed ID: 16044166
[TBL] [Abstract][Full Text] [Related]
5. Deferoxamine preconditioning to restore impaired HIF-1α-mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats.
Mehrabani M; Najafi M; Kamarul T; Mansouri K; Iranpour M; Nematollahi MH; Ghazi-Khansari M; Sharifi AM
Cell Prolif; 2015 Oct; 48(5):532-49. PubMed ID: 26332145
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of deferoxamine on experimental spinal cord injury in rat.
Liu J; Tang T; Yang H
Injury; 2011 Aug; 42(8):742-5. PubMed ID: 20850115
[TBL] [Abstract][Full Text] [Related]
7. Influences of HIF-lα on Bax/Bcl-2 and VEGF expressions in rats with spinal cord injury.
Chen MH; Ren QX; Yang WF; Chen XL; Lu C; Sun J
Int J Clin Exp Pathol; 2013; 6(11):2312-22. PubMed ID: 24228092
[TBL] [Abstract][Full Text] [Related]
8. Low-energy extracorporeal shock wave therapy for promotion of vascular endothelial growth factor expression and angiogenesis and improvement of locomotor and sensory functions after spinal cord injury.
Yahata K; Kanno H; Ozawa H; Yamaya S; Tateda S; Ito K; Shimokawa H; Itoi E
J Neurosurg Spine; 2016 Dec; 25(6):745-755. PubMed ID: 27367940
[TBL] [Abstract][Full Text] [Related]
9. Local injection of deferoxamine improves neovascularization in ischemic diabetic random flap by increasing HIF-1α and VEGF expression.
Wang C; Cai Y; Zhang Y; Xiong Z; Li G; Cui L
PLoS One; 2014; 9(6):e100818. PubMed ID: 24963878
[TBL] [Abstract][Full Text] [Related]
10. Hyperbaric oxygen intervention on expression of hypoxia-inducible factor-1α and vascular endothelial growth factor in spinal cord injury models in rats.
Zhou Y; Liu XH; Qu SD; Yang J; Wang ZW; Gao CJ; Su QJ
Chin Med J (Engl); 2013 Oct; 126(20):3897-903. PubMed ID: 24157153
[TBL] [Abstract][Full Text] [Related]
11. Comparison of deferoxamine and methylprednisolone: protective effect of pharmacological agents on lipid peroxidation in spinal cord injury in rats.
Dinc C; Iplikcioglu AC; Atabey C; Eroglu A; Topuz K; Ipcioglu O; Demirel D
Spine (Phila Pa 1976); 2013 Dec; 38(26):E1649-55. PubMed ID: 24108296
[TBL] [Abstract][Full Text] [Related]
12. HIF-1α and VEGF Are Involved in Deferoxamine-Ameliorated Traumatic Brain Injury.
Wang K; Jing Y; Xu C; Zhao J; Gong Q; Chen S
J Surg Res; 2020 Feb; 246():419-426. PubMed ID: 31630885
[TBL] [Abstract][Full Text] [Related]
13. The effect of deferoxamine on angiogenesis and bone repair in steroid-induced osteonecrosis of rabbit femoral heads.
Li J; Fan L; Yu Z; Dang X; Wang K
Exp Biol Med (Maywood); 2015 Feb; 240(2):273-80. PubMed ID: 25294892
[TBL] [Abstract][Full Text] [Related]
14. Bioactive Injectable Hydrogels Containing Desferrioxamine and Bioglass for Diabetic Wound Healing.
Kong L; Wu Z; Zhao H; Cui H; Shen J; Chang J; Li H; He Y
ACS Appl Mater Interfaces; 2018 Sep; 10(36):30103-30114. PubMed ID: 30113159
[TBL] [Abstract][Full Text] [Related]
15. Low-energy extracorporeal shock wave therapy promotes vascular endothelial growth factor expression and improves locomotor recovery after spinal cord injury.
Yamaya S; Ozawa H; Kanno H; Kishimoto KN; Sekiguchi A; Tateda S; Yahata K; Ito K; Shimokawa H; Itoi E
J Neurosurg; 2014 Dec; 121(6):1514-25. PubMed ID: 25280090
[TBL] [Abstract][Full Text] [Related]
16. Transdermal deferoxamine prevents pressure-induced diabetic ulcers.
Duscher D; Neofytou E; Wong VW; Maan ZN; Rennert RC; Inayathullah M; Januszyk M; Rodrigues M; Malkovskiy AV; Whitmore AJ; Walmsley GG; Galvez MG; Whittam AJ; Brownlee M; Rajadas J; Gurtner GC
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):94-9. PubMed ID: 25535360
[TBL] [Abstract][Full Text] [Related]
17. Desferoxamine protects against glucocorticoid-induced osteonecrosis of the femoral head via activating HIF-1α expression.
Jing X; Du T; Yang X; Zhang W; Wang G; Liu X; Li T; Jiang Z
J Cell Physiol; 2020 Dec; 235(12):9864-9875. PubMed ID: 32437020
[TBL] [Abstract][Full Text] [Related]
18. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of vascular endothelial growth factor in vitro using deferoxamine: a new drug to increase islet vascularization during transplantation.
Langlois A; Bietiger W; Mandes K; Maillard E; Belcourt A; Pinget M; Kessler L; Sigrist S
Transplant Proc; 2008 Mar; 40(2):473-6. PubMed ID: 18374106
[TBL] [Abstract][Full Text] [Related]
20. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats.
Najafi R; Sharifi AM
Expert Opin Biol Ther; 2013 Jul; 13(7):959-72. PubMed ID: 23536977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
